Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The pharmacological profile of adenosine A 1 receptors in human, guinea‐pig, rat and mouse brain membranes was characterized in a radioligand binding assay by use of the receptor selective antagonist, [3 H]‐8‐cyclopentyl‐1,3‐dipropylxanthine ([3 H]‐DPCPX). The affinity of [3 H]‐DPCPX binding sites in rat cortical and hippocampal membranes was similar. Binding site affinity was higher in rat cortical membranes than in membranes prepared from guinea‐pig cortex and hippocampus, mouse cortex and human cortex. p KD values (M) were 9.55, 9.44, 8.85, 8.94, 8.67, 9.39 and 8.67, respectively. The binding site density (B max) was lower in rat cortical membranes than in guinea‐pig or human cortical membranes. The rank order of potency of seven adenosine receptor agonists was identical in each species. With the exception of 5′‐N‐ethylcarboxamidoadenosine (NECA), agonist affinity was 3.5–26.2 fold higher in rat cortical membranes than in human and guinea‐pig brain membranes; affinity in rat and mouse brain membranes was similar. While NECA exhibited 9.3 fold higher affinity in rat compared to human cortical membranes, affinity in other species was comparable. The stable GTP analogue, Gpp(NH)p (100 μ M) reduced 2‐chloro‐N 6‐cyclopentyladenosine (CCPA) affinity 7–13.9 fold, whereas the affinity of DPCPX was unaffected. The affinity of six xanthine‐based adenosine receptor antagonists was 2.2–15.9 fold higher in rat cortical membranes compared with human or guinea‐pig membranes. The rank order of potency was species‐independent. In contrast, three pyrazolopyridine derivatives, (R)‐1‐[(E)‐3‐(2‐phenylpyrazolo[1,5‐a]pyridin‐3‐yl) acryloyl]‐2‐piperidine ethanol (FK453), (R)‐1‐[(E)‐3‐(2‐phenylpyrazolo[1,5‐a]pyridin‐3‐yl) acryloyl]‐piperidin‐2‐yl acetic acid (FK352) and 6‐oxo‐3‐(2‐phenylpyrazolo[1,5‐a]pyridin‐3‐yl)‐1(6H)‐pyridazinebutyric acid (FK838) exhibited similar affinity in human, guinea‐pig, rat and mouse brain membranes. p Ki values (M) for [3 H]‐DPCPX binding sites in human cortical membranes were 9.31, 7.52 and 7.92, respectively. Drug affinity for adenosine A 2A receptors was determined in a [3 H]‐2‐[4‐(2‐carboxyethyl)phenethylamino]‐5′‐N‐ethylcarboxamidoadenosine ([3 H]‐CGS 21680) binding assay in rat striatal membranes. The pyrazolopyridine derivatives, FK453, FK838 and FK352 exhibited p Ki values (M) of 5.90, 5.92 and 4.31, respectively, compared with p Ki values of 9.31, 8.18 and 7.57 determined in the [3 H]‐DPCPX binding assay in rat cortical membranes. These novel pyrazolopyridine derivatives therefore represent high affinity, adenosine A 1 receptor selective drugs that, in contrast to xanthine based antagonists, exhibit similar affinity for [3 H]‐DPCPX binding sites in human, rat, mouse and guinea‐pig brain membranes. British Journal of Pharmacology (1997) 122, 1202–1208; doi:10.1038/sj.bjp.0701465
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nomenclature and classification of purinoceptors.
Fredholm, B. B., Abbracchio, M. P., Burnstock, G., Daly, J. W., Harden, T. K., Jacobson, K. A., Leff, P., & Williams, M. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06782-1 · Cited by 1,585
Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
Schwabe, U., Ukena, D., & Lohse, M. J. (1985) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00572436 · Cited by 153
Cited by
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice
Young, J. W., Crawford, N., Kelly, J. S., Kerr, L. E., Marston, H. M., Spratt, C., Finlayson, K., & Sharkey, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.008 · Cited by 233
“P2 synaptosomal membranes were prepared (Maemoto et al., 1997) from pooled groups of WT, HT, and KO mouse brain tissue, and protein concentrations determined.”
MethodSelf-citationKarcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300167 · Cited by 189
O'Neill, C., Nolan, B. J., Macari, A., O'Boyle, K. M., & O'Connor, J. J. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05953.x · Cited by 37
Metadata
- Authors
- Maemoto, T., Finlayson, K., Olverman, H. J., Akahane, A., Horton, R. W., & Butcher, S. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-11
- Volume
- 122
- Issue
- 6
- Pages
- 1202-1208
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1982199478
- Cited by
- 57
- References
- 2
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. https://app.cochat.ai/papers/10.1038/sj.bjp.0701465
- The paper
- Maemoto, T., Finlayson, K., Olverman, H. J., Akahane, A., Horton, R. W., & Butcher, S. P. (1997). Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0701465
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.